Appropriateness in anti-nuclear antibody testing: From clinical request to strategic laboratory practice

Clinical and Experimental Rheumatology

Volumn 22, Issue 3, 2004, Pages 349-355

  Bizzaro, Nicola ^a   Wiik, Allan ^b  

^a Ospedale Civile   (Italy)

^b Statens Seruminstitut ^*  (Denmark)

Author keywords

Anti nuclear antibodies; Appropriateness; Autoantibody tests; Guidelines; Rheumatic diseases

Indexed keywords

ANTINUCLEAR ANTIBODY;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CONSULTATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; CLINICAL MEDICINE; PROGRAM EVALUATION; RHEUMATIC DISEASES; RHEUMATOLOGY; SEROLOGIC TESTS;

EID: 2342539777     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. BIZZARO N: L'appropriatezza nella richiesta dei test autoanticorpali per la diagnosi delle malattie reumatiche autoimmuni. Riv Med Lab 2001; 2: 11-6.
2. GRIMSHAW J, RUSSELL I: Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet 1993; 342: 1317-22.
3. OXMAN AD, THOMSON MA, DAVIS DA, HAYNES RB: No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995; 153: 1423-31.
4. SOLOMON DH, HASHIMOTO D, DALTROY L, LIANG MH: Techniques to improve physicians' use of diagnostic tests. A new conceptual framework. JAMA 1998; 280: 2020-7.
5. CABANA MD, RAND CS, POWE NR et al.: Why don't physicians follow clinical practice guidelines? JAMA 1999; 282: 1458-65.
6. SUAREZ-ALMAZOR ME, HOMIK J: Reducing serologic testing for rheumatic diseases. Feasible goal or utopian dream? J Rheumatol 1999; 26: 2505-8.
7. MÉNARD HA: Antinuclear antibodies: the medium is the message. Clin Exp Rheumatol 2000; 18: 429-30.
8. KEREN DF, HEDSTROM DL: Contemporary approaches to anti-nuclear antibody serology. J Clin Lig Assay 1999; 22: 50-5.
9. DAWKINS RL, MARTINEZ OP, FREITAS EM, HOLLINGSWORTH PN: Diagnosis of autoimmune disease. In ROSE NR and MACKAY IR (Eds.): The Autoimmune Diseases, 3rd ed. San Diego, Academic Press 1998: 821-31.
10. TAN EM, FELTKAMP TEW, SMOLEN JS et al.: Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-11.
11. SCHELLEKENS GA, de JONG BAW, van den HOOGEN FHJ, van de PUTTE LBA, van VENROOIJ WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-81.
12. BIZZARO N, MAZZANTI G, TONUTTI E, VILLALTA D, TOZZOLI R: Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001; 47: 1089-93.
13. PAWLOTSKY JM, ANDRE C, METREAU JM: Multiple nuclear dots antinuclear antibodies are not specific for primary biliary cirrhosis. Hepatology 1992; 16: 127-31.
14. TEODORESCU M, FROELICH CJ: Laboratory evaluation of systemic lupus erythematosus. In LAHITA RG (Ed.): Systemic Lupus Erythematosus, 3rd ed. San Diego, Academic Press 1999: 477-505.
15. WIIK A: ANA and ANCA. Diagnostic value and pitfalls. In HOCHBERG MC, SILMAN AJ, SMOLEN JS, WEINBLATT ME and WEISMAN MH (Eds.): Rheumatology, 3rd ed. London, Mosby 2003: 215-26.
16. SHMERLING RH: Rheumatic disease: choosing the most useful diagnostic tests. Geriatrics 1996; 51: 22-32.
17. THOMAS C, ROBINSON JA: The antinuclear antibody test. When is a positive result clinically relevant? Postgrad Med 1993; 94: 55-66.
18. VAILE JH, DYKE L, KHERANI R, JOHNSTON C, HIGGINS T, RUSSELL AS: Is high titre ANA specific for connective tissue disease? Clin Exp Rheumatol 2000; 18: 433-8.
19. TOZZOLI R, BIZZARO N, BASSETTI D et al.: Guidelines for the Laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117: 316-24.
20. CORZILLIUS M, LIANG MH: Monitoring patients with SLE. In LAHITA RG (Ed.): Systemic Lupus Erythematosus, 3rd ed. San Diego, Academic Press 1999: 467-76.
21. SOLOMON DH, KAVANAUGH AJ, SCHUR PH, and the American College of Rheumatology ad hoc Committee on Immunologic Testing Guidelines: Evidence-based guidelines for the use of immunologic tests: Antinuclear antibody testing. Arthritis Care Res 2002; 47: 434-44.
22. KAVANAUGH A, TOMAR R, REVEILLE J, SOLOMON DH, HOMBURGER HA: Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000; 124: 71-81.
23. AMIGUES JM, CANTAGREL A, ABBAL M, MAZIERES B: Comparative study of 4 diagnosis criteria sets for mixed connective tissue diseases in patients with anti-RNP antibodies. J Rheumatol 1996; 23: 2055-62.
24. MODER KG: Use and interpretation of rheumatologic tests: a guide for clinicians. Mayo Clin Proc 1996; 71: 391-6.
25. WARD MM: Laboratory testing for systemic rheumatic diseases. Postgrad Med 1998; 103: 93-100.
26. ter BORG EJ, HORST G, HUMMEL EJ, LIMBURG PC, KALLENBERG CGM: Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum 1990; 33: 634-43.
27. SWAAK AJK, GROENWOLD J, AARDEN LA, STATIUS van EPS LW, FELTKAMP TEW: Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 1982; 41: 388-95.
28. SMEENK RJT, BERDEN JHM, SWAAK AJG: dsDNA autoantibodies. In PETER JB and SHOENFELD Y (Eds.): Autoantibodies, Amsterdam, Elsevier Science BV 1996: 227-36.
29. WILSON WA, GHARAVI AE, KOIKE T et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
30. SWAAK AJG, GROENWOLD J, BRONSVELD W: Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. Ann Rheum Dis 1986; 45: 359-66.
31. Le BLANC BA, GLADMAN DD, UROWITZ MB: Serologically active clinically quiescent systemic lupus erythematosus - Predictors of clinical flares. J Rheumatol 1994; 21: 2239-41.
32. BOOTSMA H, SPRONK P, DERKSEN R et al.: Prevention of relapses in systemic lupus erythematosus. Lancet 1995; 345: 1595-9.
33. ATKINSON JC, TRAVIS WD, SLOCUM L, EBBS WL, FOX PC: Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. Arthritis Rheum 1992; 35: 1368-72.
34. HARLEY JB: Autoantibodies in Sjögren's syndrome. J Autoimmun 1989; 2: 283-94.
35. BUYON JP, WINCHESTER R: Congenital heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum 1990; 33: 609-14.
36. BUYON JP: Neonatal lupus syndromes. Am Reprod Immunol 1992; 28: 259-63.
37. HORSFALL AC, VENABLES PJ, TAYLOR PV, MAINI RN: Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block. J Autoimmun 1991; 4: 165-76.
38. WASICEK CA, REICHLIN M: Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982; 69: 835-43.
39. VENABLES PJ, SHATTLES W, PEASE CT, ELLIS JE, CHARLES PJ, MAINI RN: Anti-La(SSB): a diagnostic criterion for Sjögren's syndrome? Clin Exp Rheumatol 1989; 7: 181-4.
40. ZHANG W, REICHLIN M: Some autoantibodies to Ro/SSA and La/SSB are anti-idiotypes to anti-double stranded DNA. Arthritis Rheum 1996; 39: 522-31.
41. TARGOFF IN: Autoantibodies associated with polymyositis and dermatomyositis. Clin Aspects Autoimmun 1993; 5: 5-18.
42. YOSHIDA S, AKIZUKI M, MIMORI T, YAMAGATA H, INADA S, HOMMA M: The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue disease: A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26: 604-11.
43. REIMER G, STEEN VD, PENNING CA, MEDSGER TA, TAN EM: Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1988; 31: 525-32.
44. FRITZLER MJ, WIIK A, FRITZLER ML, BARR SG: The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 2003; 5: 192-201.
45. WIIK AS, GORDON TP, KAVANAUGH AF et al. and the IUIS/WHO/AF/CDC Committee for the Standardization of Autoantibodies in Rheumatic and Related Diseases: Cutting edge diagnostics in rheumatology: The role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Care Res (in press).
46. KUWANA M, KABURAKI J, MIMORI T, KAWAKAMI Y, TOJO T: Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosis. Arthritis Rheum 2000; 43: 1074-84.
47. van VENROOIJ WJ, CHARLES P, MAINI RN: The consensus workshop for the detection of autoantibodies to intracellular antigens in rheumatic diseases. J Immunol Methods 1991; 140: 181-9.
48. BIZZARO N, TOZZOLI R, TONUTTI E et al.: Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J Immunol Methods 1998; 219: 99-107.
49. BIZZARO N, PASINI P: Correlazione tra titolo e pattern degli anticorpi anti-nucleo in immunofluorescenza indiretta e positività degli anticorpi anti-ENA. Med Lab 1999; 7: 419.
50. HOMBURGER HA: Cascade testing for autoantibodies in connective tissue diseases. Mayo Clin Proc 1995; 70: 183-4.
51. SILMAN AJ: Epidemiology and the rheumatic diseases. In MADDISON PJ, ISENBERG DA, WOO P and GLASS DN (Eds.): Oxford Textbook of Rheumatology. Oxford, Oxford University Press 1993: 499-513.
52. JACOBSON DL, GANGE SJ, ROSE NR, GRAHAM NMH: Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997; 84: 223-43.
53. TZIOUFAS AG, MOUTSOPOULOS HM: Sjögren's syndrome. In KLIPPEL JH and DIEPPE PA (Eds.): Rheumatology, London, Mosby 1998: 32.1-32.12.
54. KEECH CL, McCLUSKEY J, GORDON T: Transfection and overexpression of the human 60-kDa Ro/SS-A autoantigen in Hep-2 cells. Clin Immunol Immunopathol 1994; 73: 146-51.
55. FRITZLER MJ, MILLER BJ: Detection of autoantibodies to SSA/Ro by indirect immunofluorescence using a transfected and overexpressed human 60 kD Ro autoantigen in HEp-2 cells. J Clin Lab Analysis 1995; 9: 218-24.
56. BROOK RH: Appropriateness: the next frontier. Br Med J 1994; 308: 218-9.